SAGE THERAPEUTICS INC

CUSIP: 78667J108 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 34,106 Value ($000) $311 Avg Close — Range —
Q1 2025
Shares 30,979 Value ($000) $246 Avg Close — Range —
Q4 2024
Shares 25,636 Value ($000) $139 Avg Close — Range —
Q3 2024
Shares 30,712 Value ($000) $222 Avg Close — Range —
Q2 2024
Shares 30,712 Value ($000) $334 Avg Close — Range —
Q1 2024
Shares 27,683 Value ($000) $519 Avg Close — Range —
Q4 2023
Shares 27,683 Value ($000) $600 Avg Close — Range —
Q3 2023
Shares 27,683 Value ($000) $570 Avg Close — Range —
Q2 2023
Shares 27,683 Value ($000) $1,302 Avg Close — Range —
Q1 2023
Shares 27,125 Value ($000) $1,138 Avg Close — Range —
Q4 2022
Shares 27,125 Value ($000) $1,035 Avg Close — Range —
Q3 2022
Shares 27,125 Value ($000) $1,062 Avg Close — Range —
Q2 2022
Shares 27,125 Value ($000) $876 Avg Close — Range —
Q1 2022
Shares 1,027 Value ($000) $34 Avg Close — Range —
Q1 2019
Shares 67 Value ($000) $11 Avg Close — Range —
Q4 2018
Shares 62 Value ($000) $6 Avg Close — Range —
Q3 2018
Shares 63 Value ($000) $9 Avg Close — Range —
Q1 2018
Shares 18,484 Value ($000) $2,977 Avg Close — Range —
Q4 2017
Shares 17,026 Value ($000) $2,804 Avg Close — Range —